WuXi AppTec (OTC:WUXAY) has announced its first interim dividend plan, distributing RMB1.03 billion in cash dividends to shareholders. The company's total shareholder returns for the year, including annual dividend, special dividend, and interim dividend, amount to RMB4.88 billion. When combined with share repurchases and cancellations, the total shareholder return reaches RMB6.88 billion, representing over 70% of the company's 2024 net profit attributable to owners.
Loading...
Loading translation...
Positive
Total shareholder returns of RMB6.88 billion in 2025, including dividends and buybacks
High payout ratio exceeding 70% of 2024 net profit
Implementation of first interim dividend shows commitment to shareholder returns
Negative
High dividend payout may limit funds available for business investment and growth
News Market Reaction – WUXAY
+2.57%
1 alert
+2.57%News Effect
On the day this news was published, WUXAY gained 2.57%, reflecting a moderate positive market reaction.
SHANGHAI, Sept. 21, 2025 /PRNewswire/ -- WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, implemented its first interim dividend plan, distributing a total of RMB1.03 billion in cash dividends.
So far this year, to enhance shareholder value, WuXi AppTec has distributed a total of RMB4.88 billion in cash dividends to investors through its annual dividend, special dividend and interim dividend. The Company's cash dividends, combined with share repurchases and cancellations implemented this year, total RMB6.88 billion, representing over 70% of the net profit attributable to the owners of the Company in 2024.
For A-share shareholders, please refer to the Company's announcement HERE. For H‑share shareholders, please refer to the Company's announcement HERE.
About WuXi AppTec
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.
FAQ
How much is WuXi AppTec's (WUXAY) interim dividend payment in 2025?
WuXi AppTec is distributing RMB1.03 billion in cash dividends through its first interim dividend plan.
What is the total amount of dividends WuXi AppTec (WUXAY) has paid in 2025?
WuXi AppTec has distributed a total of RMB4.88 billion in cash dividends through annual, special, and interim dividends in 2025.
What percentage of WuXi AppTec's 2024 net profit is being returned to shareholders in 2025?
WuXi AppTec's total shareholder returns (dividends and buybacks) of RMB6.88 billion represent over 70% of the company's 2024 net profit attributable to owners.
What types of dividends has WuXi AppTec (WUXAY) distributed in 2025?
WuXi AppTec has distributed three types of dividends in 2025: annual dividend, special dividend, and interim dividend.